Why do we need new and better antidepressants? Montgomery, Stuart A. Montgomery, Stuart A. Less International Clinical Psychopharmacology. 21:S1-S10, February 2006. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Biological rhythm disturbances in mood disorders Wirz-Justice, Anna Wirz-Justice, Anna Less International Clinical Psychopharmacology. 21:S11-S15, February 2006. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system Fuchs, Eberhard; Simon, Maria; Schmelting, Barthel Fuchs, Eberhard; Simon, Maria; Schmelting, Barthel Less International Clinical Psychopharmacology. 21:S17-S20, February 2006. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Clinical efficacy of agomelatine in depression: the evidence Den Boer, J. A.; Bosker, F. J.; Meesters, Y. Den Boer, J. A.; Bosker, F. J.; Meesters, Y. Less International Clinical Psychopharmacology. 21:S21-S24, February 2006. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Efficacy and tolerance profile of agomelatine and practical use in depressed patients Rouillon, Frédéric Rouillon, Frédéric Less International Clinical Psychopharmacology. 21:S31-S35, February 2006. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Sleep disturbances and depression: a challenge for antidepressants Lam, Raymond W. Lam, Raymond W. Less International Clinical Psychopharmacology. 21:S25-S29, February 2006. Abstract Abstract Favorites PDF Get Content & Permissions Buy
